5-Hydroxytryptamine and Its Receptor, 5-HT 7R, Facilitate Alleviation of Inflammation in Ulcerative Colitis Via Functional Regulatory B Cells

Minjie Wan,Jiawen Han,Min Rao,Feng Hu,Pujun Gao
DOI: https://doi.org/10.2139/ssrn.4016460
2022-01-01
SSRN Electronic Journal
Abstract:Background: Serotonin (5-hydroxytryptamine or 5-HT), is a neuroendocrine peptide endowed with immunomodulatory functions. Regulatory B cells (Bregs) play an important role in maintaining intestinal immune homeostasis. Our studies aimed to describe the abnormalities and association of 5-HT and Bregs in UC patients.Methods: We analyzed the differences of 5-HT and Bregs between peripheral blood of UC and healthy controls (HC). Then, we observed B cells with 5-HT treated in vitro. Besides, we adoptive transferred of 5-HT-treated B cells into colitis mice to elucidate the mechanism of 5-HT regulating Bregs to reduce intestinal inflammation.Findings: The level of serum 5-HT and IL-10 in UC patients was lower than that in HC and both of them were negatively correlated with disease activity. Reduced proportion and impaired suppressive function were observed in CD19+CD24highCD38highB from UC patients. 5-HT maintained the immune suppressor function of B220+CD5+CD1dhighB cells from mice. 5-HT 7 receptor (5-HT7R) was higher expressed on CD19+CD24highCD38highB cells in UC. In vitro, 5-HT promoted IL-10 production in CD19+CD24highCD38highB cells through the activation of STAT3. In vivo, adoptive transfer of 5-HT-treated B cells alleviated intestinal inflammation via inducing IL-10-producing B cells in mice.Interpretation: Our results suggest that 5-HT/5-HT7R signaling pathway faciliate functional Bregs in constraining inflammation in UC, which may be a new potential prospect in the treatment of UC.Funding Information: This work is supported by the grant from the National Natural Science Foundation of China (82071853), the Science and Technology Department of Jilin Province (20190201140JC), the National Natural Science Foundation of Jilin Province (JLSCZD2019-008), the National Science and Technology Major Project (2018ZX10302206, 2018ZX10723203). Declaration of Interests: The authors declare no conflicts of interest.Ethics Approval Statement: The Independent Institutional Review Board of The First Hospital of Jilin University approved the recruitment of study participants and the study protocol (permit no. 2019-322). Each study participant provided written informed consent prior to enrollment in the study. All animal experiments were approved by Animal Ethics Committee of The First Hospital of Jilin University (permit no. 0148).
What problem does this paper attempt to address?